<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04537455</url>
  </required_header>
  <id_info>
    <org_study_id>19HH5155</org_study_id>
    <nct_id>NCT04537455</nct_id>
  </id_info>
  <brief_title>Non-invasive Mapping Using Ultra-high Frequency Electrocardiography</brief_title>
  <official_title>Non-invasive Mapping Using Ultra-high Frequency Electrocardiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac electrical mapping is an important tool that allows doctors to study the electrical&#xD;
      activity of the heart in detail. Electrical mapping systems used in clinical practice are&#xD;
      time consuming, invasive and very costly. Ultra-high frequency electrocardiography is a novel&#xD;
      non-invasive cardiac mapping system. Ultra-high frequency electrocardiography (UHF-ECG) can&#xD;
      be performed in 10-15 minutes without any risk or discomfort to patients.&#xD;
&#xD;
      The aim of this study is to refine this mapping system, verify it against invasive mapping&#xD;
      and develop software to bring this novel system into routine clinical use including&#xD;
      predicting which patients will respond to cardiac resynchronisation therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single centre laboratory study aiming to utilise ultra-high frequency&#xD;
      electrocardiography to construct cardiac electrical activation maps.&#xD;
&#xD;
      All participants will attend for an UHF-ECG. This involves placing standard&#xD;
      electrocardiography electrodes (up to 48) followed by electrocardiography recording using the&#xD;
      UHF-ECG machine for 10-15 minutes.&#xD;
&#xD;
      Participants undergoing a clinically indicated VT ablation procedure will their UHF-ECG done&#xD;
      before the procedure at a separate time. The ablation procedure itself will proceed as&#xD;
      standard with no alternation whatsoever in study participants and no invasive measurements&#xD;
      will be undertaken during the procedure. After the procedure is complete the 3D electrical&#xD;
      maps collected to guide VT ablation will be analyzed and used for the study. The invasive&#xD;
      maps will be compared with the non-invasive maps obtained using UHF-EGC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients will have an ultra-high frequency electrocardiogram done.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with block in the proximal conduction system</measure>
    <time_frame>3 years</time_frame>
    <description>number of participant with an electrical activation map where the pattern indicates proximal conduction disease.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Left Bundle-Branch Block</condition>
  <condition>Right Bundle-Branch Block</condition>
  <condition>Non-Specific Intraventricular Conduction Defect</condition>
  <arm_group>
    <arm_group_label>Abnormal cardiac conduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with abnormal cardiac conduction will undergo an ultra-high frequency electrocardiogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultra-high frequency electrocardiography</intervention_name>
    <description>Patients will have an ultra-high frequency electrocardiography performed.</description>
    <arm_group_label>Abnormal cardiac conduction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (age &gt; 18 years)&#xD;
&#xD;
          -  Able to give consent&#xD;
&#xD;
          -  Some patients will be recruited from those listed for a clinically indicated VT&#xD;
             ablation&#xD;
&#xD;
          -  Patient subgroups as follows; 60 participants with LBBB undergoing a clinically&#xD;
             indicated VT ablation , 20 participants with normal 12 lead ECG and normal left&#xD;
             ventricular function assessed using standard echocardiography, 20 participants with&#xD;
             right bundle branch block morphology on 12 lead ECG, 40 participants with non-specific&#xD;
             conduction delay on 12 lead ECG, 60 participants with left bundle branch block&#xD;
             morphology on 12 lead ECG and 20 participants who developed left bundle branch block&#xD;
             morphology on 12 lead ECG after undergoing aortic valve replacement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to give consent&#xD;
&#xD;
          -  Children (age &lt; 18 years)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zachary Whinnett</last_name>
    <role>Study Director</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nadine Ali, BMBcH</last_name>
    <phone>07747462436</phone>
    <email>nadineali@doctors.org.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zachary Whinnett</last_name>
    <email>z.whinnett@imperial.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hammersmith Hospital Imperial College NHS trust</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadine Ali, BM BcH</last_name>
      <phone>07747462436</phone>
      <email>n.ali@imperial.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Zachary Whinnett, BM BS B</last_name>
      <phone>02083834967</phone>
      <email>z.whinnett@imperial.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Jurak P, Halamek J, Meluzin J, Plesinger F, Postranecka T, Lipoldova J, Novak M, Vondra V, Viscor I, Soukup L, Klimes P, Vesely P, Sumbera J, Zeman K, Asirvatham RS, Tri J, Asirvatham SJ, Leinveber P. Ventricular dyssynchrony assessment using ultra-high frequency ECG technique. J Interv Card Electrophysiol. 2017 Sep;49(3):245-254. doi: 10.1007/s10840-017-0268-0. Epub 2017 Jul 10.</citation>
    <PMID>28695377</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 28, 2020</study_first_submitted>
  <study_first_submitted_qc>August 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2020</study_first_posted>
  <last_update_submitted>August 28, 2020</last_update_submitted>
  <last_update_submitted_qc>August 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ultra-high frequency electrocardiography</keyword>
  <keyword>Left bundle branch block</keyword>
  <keyword>Cardiac resynchronization Therapy</keyword>
  <keyword>His Bundle Pacing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bundle-Branch Block</mesh_term>
    <mesh_term>Heart Block</mesh_term>
    <mesh_term>Cardiac Conduction System Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

